Brightstar Associates LLC - 07 Feb 2024 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role: 10%+ Owner
Signature: Brightstar Associates LLC, By: /s/ Greg A. Hamilton, Member of the Board of Managers
Issuer symbol: N/A
Transactions as of: 07 Feb 2024
Net transactions value: +$9,140
Form type: 4
Filing time: 09 Feb 2024, 16:30:37 UTC
Previous filing: 01 Mar 2023
Next filing: 24 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DCPH	Common Stock	Exercise of in-the-money or at-the-money derivative security	$9,140	+914,001	+4.1%	$0.0100^*	23,059,708	07 Feb 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DCPH	Warrants (right to buy)	Exercise of in-the-money or at-the-money derivative security	$0	-914,001	-95%	$0.000000	48,136	07 Feb 2024	Common Stock	914,001	$0.0100	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The warrants have no expiration date.